Aurora Spine (TSE:ASG) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Aurora Spine Corporation reported a significant increase in their first quarter financials for 2024 with a 35.7% rise in sales and a third consecutive quarter of positive EBITDAC. The company highlighted strong sales from their SiLO-TFX SI joint implant and SiLO allograft implant, which accounted for over a third of total sales. Growth is also attributed to an expanding sales force and advanced training programs for surgeons on their innovative spinal technology platforms.
For further insights into TSE:ASG stock, check out TipRanks’ Stock Analysis page.